Blog

Leaders and Trends in Intellectual Property: Probiotics

By: Andreas Baltatzis and Gideon B. Eckhouse  |   March 21, 2017

Successful health and nutrition companies are built on innovative products and great brands. The strongest foundation for this is intellectual property, specifically patents and trademarks. Patents protect inventions and trademarks protect brands. We discuss IP trends and highlight companies leading the creation of new products and brands in probiotics. 

Leaders and Trends in Intellectual Property: Joint Health Products

By: Andreas Baltatzis & Gideon Eckhouse  |   February 10, 2017

Successful health and nutrition companies are built on innovative products and great brands. The strongest foundation for new products and brands is intellectual property, specifically patents and trademarks. Patents protect inventions and trademarks protect brands. 

FDA Approves Amgen’s Amjevita

By: Sandy King  |   September 27, 2016

On Friday, September 23, 2016, the U.S. Food and Drug Administration approved Amgen Inc.’s Amjevita, which is the biosimilar equivalent of AbbVie Inc.’s immunosuppressant Humira. The drug is approved for more than a half-dozen conditions listed on the branded drug’s label, including severe psoriasis and Crohn’s disease.

Amgen v. Apotex Decision

By: Sandra King  |   July 18, 2016

On July 5, 2016, the Federal Circuit issued its decision in Amgen v. Apotex affirming an order preliminarily enjoining Apotex from launching its version of Neulasta (pegfilgrastim)...Apotex contended that they were not required to provide post-licensure notice to Amgen and that such requirement may not be enforced by an injunction.

More Enhanced Damages on the Way?

By: Andreas Baltatzis & Emily A. Curtis  |   July 5, 2016

Following 2014 opinions changing the standards for attorneys’ fees in patent cases, the Supreme Court lowered the standard for awarding treble damages in patent infringement cases. See Halo Electronics, Inc. v. Pulse Electronics, Inc., Nos. 14-1513 and 14-1520 (S.Ct. June 13, 2016). This decision will affect more than the final award given in a suit.

Pages